Pociredir
Product Specifications
UNSPSC Description
Pociredir (FTX-6058) is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). Pociredir can induce HbF protein expression in cell and murine models. Pociredir can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia[1][2].
Target Antigen
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/pociredir-1.html
Smiles
CC1=NC=CC=C1C2=CC(OC3)=C(NCC4=C(F)C=CC5=C4[C@@H]3CO5)N6C2=NN=C6
Molecular Weight
403.41
References & Citations
[1]Boerner LK. Virtual meeting delivers first time drug structures. April 12, 2021.|[2]Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139400/Pociredir-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139400/Pociredir-SDS-MedChemExpress.pdf
CAS Number
2490676-18-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1383504-01 0.02 mg (E-Coli)
Recombinant Dictyostelium discoideum 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (hibch)
Ask
View Details MBS1383504-02 0.02 mg (Yeast)
Recombinant Dictyostelium discoideum 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (hibch)
Ask
View Details